A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols
Status:
Completed
Trial end date:
2017-05-17
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-label, Phase 2 study of carfilzomib to monitor the safety and
efficacy of long-term or continuing carfilzomib therapy for patients who previously completed
a primary carfilzomib treatment study.